1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsEarly-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) is sponsored by National Cancer Institute (NCI). Funds early-stage development of informatics technologies in cancer research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Potential applicants may consider attending the pre-application webinar on September 15, 2026, 3-4pm Eastern Time. Register here .
Early-Stage Tool Development RFA-CA-27-019 : Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) This NOFO supports the early-stage development of informatics technology to improve the acquisition, management, and/or analysis of data addressing priority needs across the cancer research continuum.
Early-stage development is defined as initial tool development or the significant modification of an existing tool for a new application. Budget: Up to $300,000 Direct Costs per year for up to three years.
Enhancement & Dissemination RFA-CA-27-020 : Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) This NOFO supports the advanced development and enhancement of emerging informatics technologies to improve the acquisition, management, and/or analysis of data addressing priority needs across the cancer research continuum.
Budget: Up to $600,000 Direct Costs per year for up to five years. RFA-CA-27-021 : Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) This NOFO supports sustaining operations and improving the user experience and availability of existing, widely-adopted informatics tools and resources addressing needs across the cancer research continuum.
Budget: Up to $600,000 Direct Costs per year for up to five years.
Bioengineering Research Grants : Interdisciplinary research teams proposing to develop new tools, methods, and techniques and apply them to a specific problem in basic or clinical cancer research should consider the bioengineering research grant R01 opportunities ( PAR-22-242 or PAR-22-243 ) or the exploratory/developmental bioengineering research grant R21 opportunities ( PAR-22-090 or PAR-22-091 ).
Research teams composed of academic and industrial partners proposing to accelerate the development and adoption of promising bioengineering tools should consider PAR-22-123 .
Academic Industrial Partnerships for Translation of Technologies : Interdisciplinary research teams composed of academic and industrial partners proposing to develop and translate a technological solution to a problem in basic or clinical research should consider PAR-21-166 or PAR-21-206 .
Teams specifically focused on translating engineering developments in imaging, data science, and/or spectroscopic technologies should consider PAR-23-259 .
According to the current listing, eligibility includes: Nonprofits, Universities, State/local governments. Confirm the full requirements in the official notice before applying.
Applications for Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) are due October 20, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) is funded by National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
On May 21, 2026, the National Cancer Institute posted RFA-CA-27-006, RFA-CA-27-007, and RFA-CA-27-008 — the three competitive renewals for the NCI Community Oncology Research Program. Combined FY 2027 commitments reach $147.5 million across roughly 57 awards: $74.5 million for up to 7 Research Bases, $73 million for up to 50 Community and Academic Community Sites. Pre-application webinars run June 16-18 this week. Applications are due August 18, 2026 with six-year project periods. For community hospitals, oncology consortia, and NCI-designated cancer centers, this is the single largest cancer clinical-trials infrastructure decision NCI makes until 2033.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articlePAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read article